BERLIN, June 16, 2021 /PRNewswire/ — European medical hashish firm Cantourage right this moment launched its new and revolutionary platform, enabling cultivators from internationally to convey their product into the rising and worthwhile European market extra shortly and cheaply. Already a value chief with a major market share within the aggressive German Dronabinol market, Cantourage and its companions now supply merchandise in all related market segments – dried flowers, extracts and Dronabinol.
“We stay up for increasing our providing with the launch of our platform, which kicks off with greater than 10 companions from all continents. The present European market is dominated by only a few firms. Market entrants face many hurdles when making an attempt to enter these worthwhile markets. We empower cultivators and supply them fast-tracked, safe European market entry, whereas serving to them develop their model”, Philip Schetter, Co-CEO of Cantourage, feedback. “Our platform expands and enhances the providing to sufferers and healthcare suppliers in Europe, when it comes to each product and pricing. Extra importantly, Cantourage ensures the very best European high quality requirements for flowers from everywhere in the world. We’re set to revolutionize the market”, Dr. Florian Holzapfel, Co-founder of Cantourage, added.
Cantourage disrupts and breaks the present market oligopoly by providing unbureaucratic and quick market entry to the European market to hashish cultivators worldwide. The corporate allows cultivators to promote beneath their very own manufacturers. Via its presence in numerous segments, Cantourage goals to democratize the market, supply pharmacies and medical hashish distributors various shopping for alternatives throughout the whole market providing, and create new alternatives for the market to additional develop. Based mostly in Germany however already lively throughout Europe in 4 nations, Cantourage is set-up to scale at excessive pace.
Norman Ruchholtz, Co-CEO at Cantourage says: “The European marketplace for medical hashish is the fastest-growing, with over 20 European nations already having legalized medical hashish and gross sales anticipated to generate over $3 billion by 2025. Roughly 1 – 2% of the inhabitants is estimated to be a possible medical hashish affected person, however entry to the European marketplace for producers and the providing for sufferers continues to be extremely restricted, with only a few gamers making a quasi-oligopoly. We firmly consider – within the curiosity of our prospects – that this market is ripe for change and disruption.”
Greater than 10 cultivators from all continents, from Jamaica by to Portugal and Uruguay, have already signed on as companions and purchasers, with extra scheduled to affix in just a few weeks’ time. “Cantourage is among the few gamers that may provide the market at excessive pace – leveraging its present manufacturing and distribution networks. Our dried flower product Flos FOTMER T3h is already obtainable in German pharmacies. Along with our buyers, we are going to additional develop our European footprint and attain to service extra markets,” explains Co-founder Patrick Hoffmann.
Not too long ago, the already worthwhile firm closed its Collection B funding, led by long-term accomplice Assume.Well being Ventures. Subsequent to all earlier buyers, 10x Group joined the funding spherical which was set at a excessive double-digit million Euro valuation.
“The administration staff main Cantourage is phenomenal. Their 25-plus years of expertise, deep understanding of the market, distinctive set-up and purpose of increasing the choices available in the market makes us very excited to be on board.” explains Dr. Florian Kainzinger, CEO of Assume.Well being Ventures, which was additionally the primary enterprise capital agency in 2015 to put money into the medical hashish sector in Germany.
Cantourage with its market disrupting mannequin and the greater than 10 signed provide contracts in place, is about to develop into one of many European leaders in medical hashish.
Cantourage is a number one European medical hashish firm. The Berlin-based firm was based in 2019 by business pioneers Dr. Florian Holzapfel, Norman Ruchholtz and Patrick Hoffman. Cantourage allows producers from internationally to convey their product into the rising and worthwhile European market extra shortly and cheaply, whereas guaranteeing and additional creating highest European high quality requirements. It provides merchandise in all related market segments: dried flowers, extracts and Dronabinol, with a robust and rising market share within the latter.